Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Board Meeting Outcome for Outcome Of The Board Meeting
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Venmax Drugs & Pharmaceuticals Ltd. on 6ix
Earlier from Venmax Drugs & Pharmaceuticals
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Aug 25 2025
- Closure of Trading Window
- Board Meeting Intimation for Pursuant To Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Aug 16 2025
- Board Meeting Outcome for Outcome Of Board Meeting For Conversion Of Share Warrants And Allotment Of Equity Shares
Later from Venmax Drugs & Pharmaceuticals
- Reg. 34 (1) Annual Report.
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Sep 02 2025
- Board Meeting Outcome for Revised Outcome Of Board Meeting
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Sep 03 2025
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Sep 26 2025
Follow Venmax Drugs & Pharmaceuticals into a list and get an email when it puts out news.
Follow Venmax Drugs & Pharmaceuticals